This study describes the modulation of the rodent foreign body giant cell (FBGC) response to subcutaneously implanted, biodegradable poly(lactide-co-glycolide)/ calcium phosphate (PLGA/CaP) composites by application of a thin surface coat of calcium phosphate. Macroporous PLGA/CaP composite scaffolds, with interconnecting macroporosity, were half coated with a 3mm thick layer of CaP by immersion in simulated body fluid. Half-coated scaffolds were implanted subcutaneously in the dorsum of male Wistar rats for 1, 4 and 8 weeks. Specimens were embedded in paraffin and tissue sections evaluated by light microscopy with particular reference to the FBGC response. Histomorphometry revealed that FBGCs were in contact with 6% (± 3.5%) of the uncoated half, at 1 week, but no FBGCs were seen on the coated half. By 4 weeks, FBGCs were seen on both the uncoated and coated halves of the scaffolds with 87% (±10%) and 36% (±4%) FBGC/polymer contact respectively. By 8 weeks these FBGC contact percentages had risen to 97% (±0.45%) in the case of the uncoated halves of scaffolds, but decreased to 22% (±4%) in the case of the CaP-coated halves. Thus the CaP coating abrogated the FBGC response to the underlying polymer. Such a model may prove useful in providing an experimental system whereby both the mechanisms of biocompatibility and the transition from acute to chronic inflammation could be interrogated.
Introduction
There is a paucity of information available in the literature to describe the transition between acute and chronic inflammation. While the former is marked by local increased blood volume and leukocyte extravasation, the latter is characterized by the presence of FBGC and fibrous encapsulation (McNally and Anderson, 2002) . While much is known about each phenomenon, little is understood about the progression of one to the other. Nevertheless, the mechanisms which govern the choice between resolution of acute inflammation or progression to chronic inflammation are of critical importance in understanding not only the dichotomy between tissue regeneration and repair, but also in understanding the sequelae of the introduction of foreign materials, particularly biodegradable materials, in the body. Yet, little is understood of the cellular mechanisms driving such overt and disparate tissue reactions.
In the oldest of biomaterials applications, sutures, fibrous encapsulation of the tissue-contacting portion of such devices is an advantage both biologically, as the capsule represents an attempt to sequester the foreign body from the systemic environment, and also clinically since it facilitates removal of non-biodegradable sutures after the appropriate postoperative period. For biodegradable suture materials, such as the polyesters, like poly(lactideco-glycolide) (PLGA), the FBGC response ensures a longterm mechanism to eradicate the foreign material from the body. However, in other fields such responses provide a significant obstacle to progress. Thus, in an attempt to reduce the inflammatory response to implanted biosensors, whose function was compromised by fibrous encapsulation, Hickey et al. (2002) loaded biodegradable PLGA microspheres with dexamethasone, a synthetic cortico-steroid with known anti-inflammatory properties. PLGA has also received much attention as a delivery vehicle for vaccines where the generation of an acute inflammatory response is essential to the recruitment of dendritic cells, derived from the monocyte lineage, which act as antigen-presenting cells to trigger the required host immune response to the delivered vaccine (Paglia and Colombo, 2002) . However, the transition between this beneficial aspect of acute inflammation to a chronic inflammatory response to the PLGA which, with appearance of FBGCs, compromises the efficacy of dendritic cell antigen presentation, remains a hurdle to be overcome (Babensee et al., 2002) . Such biodegradable polyesters are, of course, widely employed in the biomaterials and tissue engineering fields where, again, their chronic degradation as a function of giant cell activity is essential in many applications such as bone plates and screws, but may be a disadvantage in tissue engineering scaffolds where polymer degradation products may have an adverse effect on the invasion of host tissue into the cell/polymer construct (Agrawal and Ray, 2001) .
Since FBGCs are the fusion products of monocytic precursors, which are also the precursors to macrophages and dendritic cells, the presence of such leukocytes in the wound healing compartment may be of central importance in driving the tissue reaction to the material (Brodbeck et al., 2002; Matheson et al., 2004) . Indeed, there is considerable evidence to illustrate the central role played by such cells. For example, Huitinga et al. (1995) showed, using a T-cell-dependent autoimmune model of encephalomyelitis, that infiltrating macrophages were crucial effectors of tissue injury and Jun et al. (1999) showed that macrophage depletion blocked disease in an animal model of autoimmune diabetes. These and other examples have been recently, and comprehensively, reviewed by Duffield (2003) . In addition, Tang et al. (1996) reported that phagocyte accumulation on implant surfaces could be abrogated by administration of recombinant neutrophil inhibitory factor that blocks the CD11b-fibrinogen interaction. Thus, while leukocyte extravasation and interaction with an implanted material are hallmarks of acute inflammation, the appearance of FBGCs would seem to be indicative of the transition from the acute to the chronic inflammatory phenomenon, without negating the possibility, as is the case with the tissue reaction to some polymeric materials, that both acute and chronic reactions may co-exist.
Such would not seem to be the case with another broad class of biomaterials, the calcium phosphates, which have long been considered biocompatible and, in general, not instigators of a FBGC response upon implantation. There are notable exceptions to this generalized statement both from the biomaterials and pathology literatures where CaP particulates have been reported to generate giant cell responses and CaPs are known to be a common cause of crystal-induced joint arthropathies respectively (O'Shea and McCarthy, 2004) . Nevertheless, CaP lithomorphs are not reported to induce a FBGC response and, although macrophage accumulation at the interface with such biomaterials must occur during the acute inflammatory phase of healing, this would not seem to transition into a FBGC response.
Given the exposure of these important gaps in our knowledge concerning the transition between acute and chronic inflammation, we report here some preliminary observations made during experiments designed to test the efficacy of a CaP coating of a biodegradable composite tissue engineering scaffold material comprising PLGA and a CaP particulate. We emphasize that the reported observations were not the reason for the original experiment, but are of sufficient interest to suggest this approach as a potential model system to interrogate the cellular and molecular mechanisms underlying the transition from acute to chronic inflammation which we believe, given the arguments presented above, may be of some interest to those working in several otherwise unconnected fields of research.
In brief, we implanted biodegradable tissue engineering scaffolds subcutaneously in rats. Half of each scaffold had been coated with a thin CaP layer that, we found, abrogated the FBGC response seen on the uncoated scaffold surface. We show that the spatial delineation of the disparate cellular responses was closely related to change in surface of the scaffold material. As such, this model may prove useful in not only exploring the mechanisms of the FBGC response as suggested above, but also deconvoluting the structure/function relationships underlying the biocompatibility of CaP materials.
Materials and Methods

Polymeric scaffolds
Macroporous PLGA (75:25) scaffolds were prepared as previously described . Briefly, PLGA (Birmingham Polymers, Birmingham, AL, USA) was dissolved in dimethylsulfoxide and thoroughly mixed with CaP particles. The resulting PLGA/CaP mixture was poured into a mold filled with fused sugar (glucose) crystals (grain size of ~0.85-1.18mm) and transferred to a fridge at -18°C for 1 hr to set. The sugar crystals were purchased form Redpath Sugar (Toronto, Ontario, Canada). The PLGA was precipitated and sugar crystals leached out by immersion in double distilled H 2 O (ddH 2 O) at room temperature (20°C) for 3 days, during which time the ddH 2 O was changed approximately 4 times per day.
Construct preparation
Discs measuring 10mm in diameter and 2mm thickness were cut from a single 10cm x 10cm x 1cm PLGA/CaP block using a stainless steel hole saw attached to a highspeed Dremel drill (Model 398) and drill press (Model 212, type II) (Dremel, Robert Bosch Tool Corporation, Mount Prospect, IL, USA) (Karp et al., 2004) . To provide physical support to the macroporous material following implantation, a perspex chamber ring (Millipore PR00 014 00) (Millipore, Billerica, MA, USA) was used to contain each scaffold. To ensure the scaffold remained within the ring, a nylon strut (Millipore PR 00 000 00) was solvent welded on each side of the ring using Millipore cement (XX70 000 72) (Fig. 1) . We refer to this protective construct as a "cage". CaP coating of PLGA In addition to the CaP phase embedded within the polymeric structure, a thin surface layer of CaP was deposited onto half of the scaffolds using the following solution chemistry technique. Samples to be coated were pre-wetted in 70% ethanol, and rinsed in deionised water. Half of the scaffold was immersed in concentrated [x 5] simulated body fluid (SBF: Na + 142.0mM, K + 5.0mM, Mg 2+ 1.5mM, Ca 2+ 2.5mM, Cl -147.8mM, HCO 3-4.2mM, HPO 4 2-1.0mM, SO 4 2-0.5mM) and maintained at 37°C for a period of 5 days, with daily changes of SBF .
Scanning electron microscopy (SEM)
SEM was used to examine the microstructure of the coated scaffold and to ensure that only half of the scaffold had been coated with CaP. Following immersion in SBF, samples were rinsed in ddH 2 O, air dried, coated with platinum and examined using a Hitachi S2500 SEM (Hitachi, Tokyo, Japan).
Subcutaneous implantation
The following implantation protocol was reviewed and approved by the Animal Ethics Committee of the University of Toronto. Nine male Wistar rats, weighing approximately 200g, were anaesthetized using Isofluorane. An incision was made in the dorsal cutis and a subcutaneous pocket was created using blunt dissection. A half coated scaffold, contained within a cage, was placed in this pocket and the overlying skin closed using staples. Constructs were left insitu for 1, 4 and 8 weeks (n= 3 per time point). Animals received postoperative analgesia via subcutaneous administration of buprenorphine (0.05mg/kg) and were left to recover under a heat lamp. Following recovery, animals received food and water ad libitum.
Histological preparation
Following euthanasia, constructs with surrounding soft tissue were removed and fixed in formalin for 48hrs. The nylon struts were fractured at the solvent weld points and pulled out of the tissue. Then, using a razor blade, the surrounding tissue was separated from the outer perimeter of the Perspex ring and the scaffold and related tissue removed from the ring. The scaffold/tissue specimen was then bisected and embedded in paraffin. Sections, 6mm thick, were cut from the paraffin blocks, were stained with haematoxylin and eosin and qualitatively examined using a light microscope (Olympus BX51) (Olympus, Melville, NY, USA) interfaced with a digital camera (SPOT RT, Digital Instruments; now Veeco Instruments, Woodbury, NY, USA) running SPOT software. Particular attention was paid to the number and distribution of FBGCs.
Quantitative analysis
To facilitate measurement of the FBGC response, light microscopic digital images were acquired using a 10x objective lens. An average of eight micrographs were taken for each slide to ensure coverage of the entire tissue section. Lines were traced around the contact surfaces of PLGA with repair tissue on each image using Adobe Photoshop (Adobe Inc., San Jose, CA, USA). Green lines were used to represent the surfaces of PLGA polymer that were free of FBGC and red lines used to represent the areas where FBGCs were in direct contact with the polymer (Fig. 2) . Following determination of FBGC contact surface, Image J software (http://rsb.info.nih.gov/ij/) was used to convert the contact surface measurement into a FBGC linear contact percentage. Data was expressed as mean ± standard deviation (n=3 for each time point).
Results
Scanning electron microscopy SEM revealed a confluent crystalline layer, approximately 3 µm thick, on the part of the scaffold immersed in SBF. Imaging the junction between the uncoated and coated areas demonstrated that the material had been successfully half coated; although the junction between the coated and uncoated halves was imperfect since some sites of calcium phosphate nucleation extended randomly to a distance of about 50 µm from the solid boundary (Fig. 3 ).
Histological observations
1 week (not shown). By one week, a loose, fibrovascular tissue had penetrated throughout the pores of all constructs on both coated and uncoated sides of the scaffolds. Small numbers of FBGCs were identified in the tissue adjacent to the uncoated side but these were not a prominent histological feature. A similar tissue response was seen in the coated half, however no FBGCs were observed. 4 weeks. At low magnification the stark contrast in tissue response between the two halves of the scaffold could be observed (Fig. 4) . The uncoated portion of the scaffolds had provoked a robust FBGC response. Numerous FBGCs were observed in dense collagenous tissue adjacent to the degrading polymer, lining the interface between tissue and polymer (Fig. 5a) . In sharp contrast, the coated portion of the scaffolds showed little accumulation of FBGC either deep to, or in direct contact with, the CaP coating (Fig. 5b) .
8 weeks. By 8 weeks the uncoated polymer had been extensively degraded resulting in fragmentation of the polymer into numerous sites, each surrounded by multiple FBGCs (Fig. 6a) . In contrast, the CaP coated half had not fragmented and retained its open pore structure. Occasional FBGCs were observed adjacent to the CaP coating (Fig. 6b) .
Histomorphometry
The FBGC/polymer contact at 1 week was approximately 6% (± 3.5%) on the uncoated half, and zero on the coated half (Fig. 7) . By 4 weeks this had increased on both the uncoated and coated halves to 87% (±10%) and 36% (±4%) respectively. At 8 weeks, the FBGC contact with the uncoated half had increased again to 97% (±0.45%), while that on the coated half had decreased to 22% (±4%). . Low magnification image obtained using a stereo dissecting microscope of a complete cross section of an embedded scaffold and "cage" after 4 wks implantation. The empty areas (*) at right and left were those filled by the diffusion chamber ring, while those (+) top and bottom represent the cross-sections of the nylon protective bars. The scaffold has been bisected, within the "cage" so that the left half is the coated half (CaP) and the right half is uncoated (P). Note: the contrast in tissue response between the coated and uncoated halves is easily visible at this magnification, as is the apparent increase in number of scaffold fragments in the uncoated half. Haematoxylin and eosin. Bar = 5 mm. 
Discussion
Our results show that a simple 3µm thick surface coating of CaP (Lickorish et al., 2004) can abrogate the rodent FBGC response to an implanted PLGA/CaP scaffold. This host response was sharply contrasted on the opposing sides of each scaffold, and the spatial delineation of the disparate cellular responses was closely related to change in surface of the scaffold material. Thus, while the acute inflammatory response to the uncoated surface transitioned to a chronic inflammation with FBGCs in contact with 97% of the available scaffold surface by 8 weeks, the FBGC response to the coated side was significantly less at 4 weeks and, unlike that to the uncoated side, decreased to 22% by 8 weeks. This dramatic difference in host reaction within the same biological system may provide an in-vivo model by which mechanisms of inflammatory biology may be investigated. The ability to control the inflammatory response holds great significance for those attempting to introduce foreign materials into the body, whether these materials be biodegradable polymers for tissue engineering purposes, biosensors to monitor physiological fluctuations, vaccines designed to generate an immune response or orthopaedic devices used in arthroplasty. Clearly, implantation of a foreign material within the body will provoke an acute inflammation; an unavoidable consequence of tissue injury. However, what is unclear, and largely overlooked, are the mechanisms by which this ordinarily transient phenomenon fails to resolve, leading to the development of a chronic inflammation that is widely described as detrimental to biomaterial function (Anderson, 1988) . Polymers have proven popular materials from which to fabricate implantable devices for a wide range of tissue engineering applications. More specifically, polyesters such as polyglycolic acid (PGA), polylactic acid (PLA) and their co-polymer, PLGA, feature prominently as resorbable fracture fixation plates in the orthopaedic field (Eppley, 1998) , as microparticles for introduction of vaccines and drugs and as resorbable porous scaffolds for cell delivery (Chandrashekar and Udupa, 1996; Kempen et al., 2004) . Whilst much of the literature describes biodegradable polyester materials as being biocompatible, there are reports that implantation of these materials may result in a chronic inflammatory response (Solheim et al., 2000; Bostman and Pihlajamaki, 2000) . Little data is available on how this phenomenon is mediated, but chronic inflammation is often attributed to the irritant effect of a local reduction in pH, due to acidic polymeric degradation products (Agrawal and Athanasiou, 1997) .
CaP has a well documented history as a biocompatible material and continues to be a successful clinical adjunct, even replacement, to the bone graft in orthopaedic procedures. But, the reason for this biocompatibility, indeed, even the mechanism through which CaP may modulate the inflammatory response, is also similarly poorly understood. In an orthopaedic context, the coating of materials with CaP has generally been performed to improve the osteoconductive properties of the material being coated. Using SBF, materials ranging in composition from metallic, ceramic to polymeric (Tanahashi et al., 1995; Lickorish et al., 2004; Barrere et al., 1999 , Leng et al., 2003 have been coated with a thin layer of CaP and chronic inflammation has not been reported following in-vivo implantation of these materials. There are several possible mechanisms by which CaP could influence the FBGC response. These include, but are not limited to, effects of CaP on surface protein adsorption and monocyte/ macrophage attachment, proliferation, and fusion.
The role of protein adsorption
The adsorption of proteins, principally those of the complement and coagulation cascades, to a biomaterial surface following implantation into the body is thought to play a significant role in the subsequent tissue response (Janatova, 2000) . The species and conformation of adsorbed proteins present on a biomaterial may influence monocyte adhesion, subsequent differentiation and proliferation of macrophages on the implant surface, (Tang et al., 1996; Hu et al., 2001 ) and may even be responsible for encouraging macrophage fusion into FBGCs. Few data are available on the specific protein species that adsorb preferentially onto PLGA versus CaP. Indeed, this has been notoriously difficult to study (Collier et al., 2004) . Nevertheless, it is not unreasonable to speculate that the sharp delineation between tissue response to the CaP and PLGA, observed in the present study, could be a function of adsorbed proteins attributed to the differing surface chemistry and/or topography (Jenney and Anderson, 2000) . Since a CaP coating reduces the likelihood for formation of the FBGC, this offers an attractive alternative antigen delivery vehicle, as CaP coated microspheres, to dendritic cells, especially if the antigen could be incorporated within the coating to maintain dose rates over time as the CaP is resorbed.
The role of macrophages
Manipulation of host protein layer by surface functionalization or modification is a popular method to promote/inhibit cell interactions with implanted materials (DeFife et al., 1999; Healy 1999; Collier and Anderson, 2002) . Hu et al. (2001) reported the involvement of adsorbed fibrinogen as playing a key role in the attraction of phagocytic cells to the surfaces of implanted materials. Indeed, macrophages play a pivotal role in the inflammatory response (Anderson and Miller, 1984) . Appropriately, strategies designed to modulate inflammation following biomaterial implantation attempt to directly influence the interaction of the macrophage with the biomaterial, reasoning that if a surface is sufficiently inhospitable to monocyte adhesion then subsequent macrophage maturation and FBGC formation is unlikely to follow (Hamilton 2003; Collier et al., 2004) . Such strategies have included incorporation of non steroidal antiinflammatory agents within polymer microspheres (Hickey et al., 2002) . Kao and Lee (2001) describe the importance of the RGD and PHSRN regions of the fibronectin molecule in modulating the host response, macrophage adhesion and FBGC formation in-vivo. Incorporation of vitamin E onto a polyurethane biomaterial resulted in reduced FBGC-mediated degradation (Schubert et al., 1996) . Iwasaki et al. (2002) blended 2-methacryloyloxyethyl phosphorylcholine (MPC) with PLGA to reduce the inflammatory reaction of adherent cells whilst Khouw et al. (1998) used antibodies against interferon gamma, a T cell derived cytokine known to activate macrophages, to delay the formation and function of FBGC. Clearly, the numerous ways by which macrophagebiomaterial interactions can be affected underscores the complexity of the host response.
Macrophage fusion
Once macrophages have adhered to a surface, the molecular mechanism describing their fusion to form FBGC is also unclear (Matheson et al., 2004) though macrophage fusion receptor, CD44 and CD47 have been reported as playing a role in promoting fusion (Vignery, 2000) . Cytokines have also been implicated in fusion as the inability of macrophages to phagocytose large amounts of material, so called 'frustrated phagocytosis ' (Matzelle and Babensee, 2004) , may encourage production of proinflammatory mediators to recruit assistance. IL-4 and IL-13 have been shown to induce FBGC formation in-vitro (McNally and Anderson, 2002) . Such could encourage progression to a chronic inflammation in-vivo if there is a shift in the equilibrium between pro-and anti-inflammatory chemokines. Furthermore, it has been reported that macrophages greater than 8 days old (Most et al., 1997) , or less than a certain 'critical density' (Vignery, 2000) , show almost no fusion into FBGCs, the former highlighting the importance of unravelling the temporal nature of macrophage interaction with a material and the latter supporting the underlying rationale for attempting to modulate initial monocyte adhesion to the biomaterial.
Concluding remarks
In this preliminary study we have rendered a macroporous PLGA/CaP scaffold 'anti-inflammatory', by simply incorporating a thin surface film of CaP. The significance of this brief study lies, firstly, in the fabrication of a material that can modulate the inflammatory response and secondly, in describing an in-vivo model that enables us to address questions regarding the transition from acute to chronic inflammation. The inflammatory response involves a complex interplay between a myriad of signaling molecules, produced by and intended for, a wide variety of cells, and it is clear that to engineer the requisite level of control over this process, a greater appreciation of the basic biology involved is needed. Thus, this novel experimental approach will enable further interrogation of the mechanisms of acute and chronic inflammation. Moreover, in addition to illuminating the mechanisms governing the progression from acute to chronic inflammation, this model will enable the mechanisms of polyester and CaP biocompatibility to be further dissected. This approach may encourage dialogue between unconnected fields which, despite divergent applications, share a similar interest in understanding and controlling the adverse inflammatory response.
